Efficacy and safety of flecainide for ventricular arrhythmias

Figure 1 Heart Rhythm 2015 12596 -603 DOI: (10. 1016/j. hrthm. 2014. 12. 009)

Figure 2 Heart Rhythm 2015 12596 -603 DOI: (10. 1016/j. hrthm. 2014. 12. 009)

Figure 3 Heart Rhythm 2015 12596 -603 DOI: (10. 1016/j. hrthm. 2014. 12. 009)

Figure 4 Heart Rhythm 2015 12596 -603 DOI: (10. 1016/j. hrthm. 2014. 12. 009)

Slides: 5

Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen. Tawil syndrome with KCNJ 2 mutations Koji Miyamoto, MD, Takeshi Aiba, MD, Ph. D, Hiromi Kimura, MD, Ph. D, Hideki Hayashi, MD, Ph. D, Seiko Ohno, MD, Ph. D, Chie Yasuoka, MD, Ph. D, Yoshihito Tanioka, MD, Ph. D, Takeshi Tsuchiya, MD, Ph. D, Yoko Yoshida, MD, Hiroshi Hayashi, MD, Ippei Tsuboi, MD, Ikutaro Nakajima, MD, Kohei Ishibashi, MD, Hideo Okamura, MD, Takashi Noda, MD, Ph. D, Masaharu Ishihara, MD, Ph. D, Toshihisa Anzai, MD, Ph. D, Satoshi Yasuda, MD, Ph. D, Yoshihiro Miyamoto, MD, Ph. D, Shiro Kamakura, MD, Ph. D, Kengo Kusano, MD, Ph. D, Hisao Ogawa, MD, Ph. D, Minoru Horie, MD, Ph. D, Wataru Shimizu, MD, Ph. D Heart Rhythm Volume 12 Issue 3 Pages 596 -603 (March 2015) DOI: 10. 1016/j. hrthm. 2014. 12. 009 Copyright © 2015 Heart Rhythm Society Terms and Conditions